Dr Reddys launches Valsartan in US Ruchika Sharma10 Dec 2021 3:26 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd. has announced the launch of Valsartan Tablets, USP in the U.S. Market.The product is a therapeutic...
Parenteral iron followed by oral iron effective strategy for treating HFpEF: Study Medha Baranwal8 Dec 2021 9:00 AM ISTMumbai, Maharashtra: Parenteral iron carboxymaltose followed by oral iron supplementation is an effective treatment strategy in patients with heart...
Macitentan improves Cardiopulmonary structure and function in PAH patients MD Editorial Team7 Dec 2021 9:00 AM ISTA recent study found that Macitentan medication resulted in significant and clinically important improvements in right ventricular (RV) function and...
Quality of life in heart failure patients may be improved with Canagliflozin category Dr. Nandita Mohan5 Dec 2021 11:30 AM ISTThe CHIEF- HF trial results have shown that treating heart failure (HF) patients with canagliflozin a sodium-glucose cotransporter 2 (SGLT2)...
Sacubitril/valsartan decreases plasma NT-proBNP in HF patients with preserved ejection fraction: JAMA Medha Baranwal3 Dec 2021 9:00 AM ISTGermany: Sacubitril/valsartan significantly decreased plasma NT-proBNP levels at 12 weeks compared with standard medical therapies in patients with...
Empagliflozin safe in acute HF, improves 'Clinical Benefit' over time Dr. Nandita Mohan2 Dec 2021 10:42 AM ISTPatients with acute heart failure were safely started on empagliflozin a median of 3 days after hospitalization and were 36% more likely to...
Medical Bulletin 30/November/2021 Dr. Nandita Mohan30 Nov 2021 5:25 PM ISTHere are Top Medical stories of the daySevere hypoglycemia related to heart failure risk in T2DSevere hypoglycemia is associated with a greater risk...
Severe hypoglycemia related to heart failure risk in type 2 diabetes patients: Study Medha Baranwal29 Nov 2021 10:15 AM ISTUSA: Severe hypoglycemia is associated with a greater risk of heart failure, reveals a study of a large cohort of adults with type 2 diabetes. The...
Sacubitril/Valsartan does not best valsartan in patients with advanced heart failure: LIFE Trial Medha Baranwal24 Nov 2021 9:00 AM ISTThe trial found no significant improvements with the combination drug when compared with valsartan in terms of the primary endpoint.USA:...
Aspirin intake potentially linked to incident heart failure: ESC study Dr Kartikeya Kohli23 Nov 2021 11:37 AM ISTAspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. Predisposing...
What ESC 2021 guidelines say about use of Mineralocorticoid Receptor Antagonist (MRA) in HFrEF? Dr. Prem Aggarwal18 Nov 2021 11:57 AM ISTThe European Society of Cardiology (ESC) has recently issued guidelines to include Mineralocorticoid Receptor Antagonist (MRA) besides ACE-I and...
MRA Strongly Recommended in Treatment of Heart Failure with Reduced Ejection Fraction: 2021 ESC Guidelines Medical Dialogues Bureau17 Nov 2021 12:45 PM ISTPharmacotherapy is the cornerstone of treatment for Heart Failure with Reduced Ejection Fraction (HFrEF) and should be implemented before considering...
